207 related articles for article (PubMed ID: 15497018)
1. Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin.
Glueck CJ; Wang P; Goldenberg N; Sieve L
Clin Appl Thromb Hemost; 2004 Oct; 10(4):323-34. PubMed ID: 15497018
[TBL] [Abstract][Full Text] [Related]
2. Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss.
Ramidi G; Khan N; Glueck CJ; Wang P; Goldenberg N
Transl Res; 2009 Jan; 153(1):33-43. PubMed ID: 19100956
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: associations with recurrent pregnancy loss.
Glueck CJ; Wang P; Bornovali S; Goldenberg N; Sieve L
Metabolism; 2003 Dec; 52(12):1627-32. PubMed ID: 14669168
[TBL] [Abstract][Full Text] [Related]
4. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovary syndrome, infertility, familial thrombophilia, familial hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage.
Glueck CJ; Awadalla SG; Phillips H; Cameron D; Wang P; Fontaine RN
Fertil Steril; 2000 Aug; 74(2):394-7. PubMed ID: 10927066
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin.
Glueck CJ; Wang P; Goldenberg N; Sieve-Smith L
Hum Reprod; 2002 Nov; 17(11):2858-64. PubMed ID: 12407039
[TBL] [Abstract][Full Text] [Related]
7. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study.
Glueck CJ; Phillips H; Cameron D; Sieve-Smith L; Wang P
Fertil Steril; 2001 Jan; 75(1):46-52. PubMed ID: 11163815
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
Glueck CJ; Sieve L; Zhu B; Wang P
Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
[TBL] [Abstract][Full Text] [Related]
9. Correlation between thrombophilia and recurrent pregnancy loss in patients with polycystic ovary syndrome: a comparative study.
Kazerooni T; Ghaffarpasand F; Asadi N; Dehkhoda Z; Dehghankhalili M; Kazerooni Y
J Chin Med Assoc; 2013 May; 76(5):282-8. PubMed ID: 23683262
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome.
Glueck CJ; Wang P; Fontaine RN; Sieve-Smith L; Tracy T; Moore SK
Metabolism; 1999 Dec; 48(12):1589-95. PubMed ID: 10599993
[TBL] [Abstract][Full Text] [Related]
11. Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss.
Sarig G; Blumenfeld Z; Leiba R; Lanir N; Brenner B
Thromb Haemost; 2005 Nov; 94(5):980-5. PubMed ID: 16363240
[TBL] [Abstract][Full Text] [Related]
12. [Treatment with enoxaparin adapted to the fertility programs in women with recurrent abortion and thrombophilia].
Sarto A; Rocha M; Geller M; Capmany C; MartÃnez M; Quintans C; Donaldson M; Pasqualini RS
Medicina (B Aires); 2001; 61(4):406-12. PubMed ID: 11563168
[TBL] [Abstract][Full Text] [Related]
13. The factor V Leiden mutation, high factor VIII, and high plasminogen activator inhibitor activity: etiologies for sporadic miscarriage.
Glueck CJ; Pranikoff J; Aregawi D; Haque M; Zhu B; Tracy T; Wang P
Metabolism; 2005 Oct; 54(10):1345-9. PubMed ID: 16154434
[TBL] [Abstract][Full Text] [Related]
14. Hypofibrinolysis, thrombophilia, osteonecrosis.
Glueck CJ; Freiberg RA; Fontaine RN; Tracy T; Wang P
Clin Orthop Relat Res; 2001 May; (386):19-33. PubMed ID: 11347834
[TBL] [Abstract][Full Text] [Related]
15. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.
Visser J; Ulander VM; Helmerhorst FM; Lampinen K; Morin-Papunen L; Bloemenkamp KW; Kaaja RJ
Thromb Haemost; 2011 Feb; 105(2):295-301. PubMed ID: 21103659
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of threatened abortions after anticoagulation treatment to prevent recurrent pregnancy loss.
Rottenstreich A; Amsalem H; Kleinstern G; Kalish Y
Reprod Biomed Online; 2017 Oct; 35(4):461-467. PubMed ID: 28756129
[TBL] [Abstract][Full Text] [Related]
17. Effects of metformin-diet intervention before and throughout pregnancy on obstetric and neonatal outcomes in patients with polycystic ovary syndrome.
Glueck CJ; Goldenberg N; Pranikoff J; Khan Z; Padda J; Wang P
Curr Med Res Opin; 2013 Jan; 29(1):55-62. PubMed ID: 23205605
[TBL] [Abstract][Full Text] [Related]
18. Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome.
Glueck CJ; Bornovali S; Pranikoff J; Goldenberg N; Dharashivkar S; Wang P
Diabet Med; 2004 Aug; 21(8):829-36. PubMed ID: 15270785
[TBL] [Abstract][Full Text] [Related]
19. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia.
Carp H; Dolitzky M; Inbal A
J Thromb Haemost; 2003 Mar; 1(3):433-8. PubMed ID: 12871446
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia.
Glueck CJ; Aregawi D; Goldenberg N; Golnik KC; Sieve L; Wang P
J Lab Clin Med; 2005 Feb; 145(2):72-82. PubMed ID: 15746649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
